Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cerus Corp
(NQ:
CERS
)
1.819
-0.041 (-2.19%)
Streaming Delayed Price
Updated: 9:58 AM EST, Nov 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cerus Corp
< Previous
1
2
3
4
5
6
Next >
Cerus Corporation to Release Third Quarter 2021 Financial Results on November 2, 2021
October 19, 2021
From
Cerus Corporation
Via
Business Wire
Cerus Corporation Applauds FDA Requirements Effective Today to Safeguard the U.S. Platelet Supply
October 01, 2021
From
Cerus Corporation
Via
Business Wire
Cerus Corporation Announces INTERCEPT Fibrinogen Complex Customer Presentations at SABM Virtual Annual Meeting 2021
September 20, 2021
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Present at the 2021 Cantor Global Virtual Healthcare Conference
September 15, 2021
From
Cerus Corporation
Via
Business Wire
Delta Variant Fears Continue
September 09, 2021
The jobless level fell to 310,000 whereas the consensus forecast was for 335,000, so risks of inflation are higher.
Via
Talk Markets
Cerus Corporation Announces CMS Issuance of P-Codes for Hospital Outpatient Billing of INTERCEPT-Based Therapeutic Products
August 10, 2021
From
Cerus Corporation
Via
Business Wire
Cerus Corporation Announces Appointment of Ann Lucena to Board of Directors
August 04, 2021
From
Cerus Corporation
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 04, 2021
Gainers BeyondSpring (NASDAQ:BYSI) stock increased by 337.79% to $42.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6...
Via
Benzinga
88 Biggest Movers From Yesterday
August 05, 2021
Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in...
Via
Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
30 Stocks Moving in Wednesday's Pre-Market Session
August 04, 2021
Gainers Alterity Therapeutics Limited (NASDAQ: ATHE) shares rose 34.8% to $1.84 in pre-market trading after gaining around 3% on Tuesday. Wheeler Real Estate Investment Trust,...
Via
Benzinga
Cerus Stock Gains As Q2 Earnings Match Expectations, Raises FY21 Sales Guidance
August 04, 2021
Cerus Corporation (NASDAQ: CERS) reported second-quarter sales of $37.8 million, +41% Y/Y in line with the consensus. Product revenue reached $31.5 million, compared to...
Via
Benzinga
Topics
Earnings
Exposures
Financial
Cerus Corporation (CERS) Q2 2021 Earnings Call Transcript
August 04, 2021
CERS earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 03, 2021
Gainers Cerus (NASDAQ:CERS) shares incre...
Via
Benzinga
14 Stocks Moving In Tuesday's After-Hours Session
August 03, 2021
RingCentral (NYSE: RNG) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued Q3 and FY21 EPS and sales guidance above...
Via
Benzinga
Recap: Cerus Q2 Earnings
August 03, 2021
Shares of Cerus (NASDAQ:CERS) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were unchanged 0.00% over the past year to...
Via
Benzinga
Cerus Corporation Announces Record Second Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance
August 03, 2021
From
Cerus Corporation
Via
Business Wire
Cerus Corporation Announces CMS Has Granted New Technology Add-On Payment for INTERCEPT Fibrinogen Complex
August 03, 2021
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Release Second Quarter 2021 Financial Results on August 3, 2021
July 20, 2021
From
Cerus Corporation
Via
Business Wire
Delta Defeats Bulls
July 19, 2021
Stocks tended to crash without rhyme or reason.
Via
Talk Markets
Weak Week
July 16, 2021
Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism.
Via
Talk Markets
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
July 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
July 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Stocks That Hit 52-Week Lows On Wednesday
July 14, 2021
Wednesday morning saw 57 companies set new 52-week lows. Noteworthy Points: Campbell Soup (NYSE:CPB) was the largest firm by market cap to set a new 52-week low....
Via
Benzinga
Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets
July 14, 2021
From
Cerus Corporation
Via
Business Wire
Cramer Gives His Opinion On AT&T, Cemex And More
July 11, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said he is not a fan of AT&T Inc. (NYSE: T). For growth, he would go with T-Mobile Us Inc (NASDAQ: TMUS) and...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
July 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...
Via
Benzinga
End Of June
June 30, 2021
Canadian Solar fell 4.6% on fears of plans for a China IPO where its panels are made.
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Cerus Announces Collaboration with LifeSouth Community Blood Centers to Manufacture INTERCEPT® Fibrinogen Complex
June 30, 2021
From
Cerus Corporation
Via
Business Wire
Cerus Corporation Celebrates World Blood Donor Day 2021
June 14, 2021
From
Cerus Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.